This is a practical guide to getting Mounjaro (tirzepatide) in Nova Scotia in 2026. I cover T2D public coverage, private insurance for off-label weight management, what to expect at the pharmacy counter, the best online providers for Nova Scotians, the myMounjaro savings card and how Mounjaro stacks up against Ozempic and Wegovy on cost. Pricing reflects April 2026 quotes.
If Mounjaro is new to you, start with Mounjaro in Canada for the full overview. If you want the lowest price, see Cheapest Mounjaro in Canada. To compare telehealth providers, read Best Mounjaro Providers in Canada.
- Approved use: Mounjaro is Health Canada-approved for type 2 diabetes only. Weight-management use is off-label until Eli Lilly’s tirzepatide weight-loss brand (Zepbound, marketed in the United States) launches in Canada. [1]
- Nova Scotia Pharmacare coverage: Nova Scotia Pharmacare does not list Mounjaro on its formulary as of April 2026. [2]
- Retail pricing: Mounjaro in Nova Scotia runs roughly $280 to $310 per month at the 2.5 mg starter dose, scaling to $500 to $550 at the 15 mg maintenance dose. Costco Pharmacy is consistently cheapest where available.
- Savings card: Eli Lilly Canada’s myMounjaro patient-support program offsets $100 to $150 per month for eligible patients without provincial drug-plan coverage. [3]
- Generic timeline: No generic Mounjaro is on the Canadian horizon - Eli Lilly’s tirzepatide patents run well into the 2030s. Generic semaglutide (Ozempic) arrives May 2026 and may shift cost-sensitive patients toward semaglutide. [8]
Generic semaglutide is now also available in-person at Canadian pharmacies including Shoppers Drug Mart, Rexall, Costco, and Walmart, typically priced at $85 to $120 per month depending on the pharmacy — with Costco usually lowest. That makes the in-person retail route generally cheaper than telehealth providers like Felix Health, which charges $149 per month for the same generic.
How to Get Mounjaro in Nova Scotia
Nova Scotians have three realistic paths to a tirzepatide prescription:
- Family doctor or nurse practitioner: Best if you already have a relationship with a primary-care provider. Most family physicians in Nova Scotia now prescribe Mounjaro for type 2 diabetes; off-label weight-management requests are handled case-by-case.
- Canadian telehealth: Felix Health and Maple are the two clinics that actively prescribe Mounjaro across most of Canada. Hims Canada also prescribes tirzepatide where it operates. Jill Health, DooU and Raven generally default to off-label Ozempic.
- Endocrinologist or obesity-medicine specialist: For complex T2D management or BMI 40+ off-label weight cases, a referral to a specialist clinic in Nova Scotia gives you access to structured monitoring alongside the medication.
Once you have a Mounjaro prescription, fill it at any licensed Canadian pharmacy in Nova Scotia. Coverage and pricing differ depending on whether you go through Nova Scotia Pharmacare, private insurance or self-pay - the next sections walk through each.
Does Nova Scotia Pharmacare Cover Mounjaro in Nova Scotia?
Nova Scotia Pharmacare does not list Mounjaro on its formulary as of April 2026. The province is awaiting its provincial review following pCPA. Until a listing decision lands, Nova Scotians cover Mounjaro through private insurance or self-pay. [2]
Halifax, Sydney and Dartmouth Pharmacare subscribers (Family, Seniors, MSI) cannot claim Mounjaro through the public plan.
For the nationwide view of public and private coverage rules, see Mounjaro Insurance Coverage in Canada. For an off-label weight-management view, the Wegovy alternative is documented at Wegovy in Nova Scotia.
Private Insurance Coverage for Mounjaro in Nova Scotia
Private insurance is the cheapest realistic path for most Mounjaro users in Nova Scotia. The major insurers active here are Manulife, Sun Life, Canada Life, Green Shield and Medavie Blue Cross. [3] Coverage is rarely automatic - prior authorization is required almost universally for tirzepatide.
Typical Prior-Authorization Criteria
- Confirmed type 2 diabetes diagnosis (most common path). For weight management: BMI 30 or higher, or 27 or higher with a comorbidity such as hypertension, dyslipidemia or sleep apnea.
- Step-therapy documentation showing prior trial of metformin (for T2D) or another anti-obesity medication (for weight management).
- Recent A1C, fasting glucose and lipid-panel results.
- Prescriber letter outlining the clinical rationale for choosing tirzepatide over a cheaper alternative.
What Approved Coverage Looks Like
If approved, most Nova Scotia private plans reimburse 70 to 90 percent of the Mounjaro pen cost subject to your plan’s annual cap. Typical out-of-pocket after prior auth is $40 to $135 per month, down from the $280 to $550 retail range.
Medavie Blue Cross is the dominant Atlantic-Canada insurer and many Nova Scotia employer plans run through it. Medavie Blue Cross will typically reimburse Mounjaro for type 2 diabetes with prior authorization. Off-label weight-management coverage depends on the specific group plan.
Best Online Providers for Nova Scotians
Telehealth is often the fastest path to a Mounjaro prescription in Nova Scotia, especially because endocrinology and obesity-medicine wait lists run long. The six Canadian providers I track are below - note that not all of them prescribe Mounjaro, and provincial availability varies.
Top pick: MyRocky (operated by Rocky Health Inc.) is our highest-rated Canadian GLP-1 provider in 2026 (9.4/10). Per-pen pricing is roughly comparable across the major Canadian telehealth services - what MyRocky wins on is total value: the $99 one-time consult includes lab work and the first prescription, there are no recurring quarterly fees, free fast delivery is included, and it operates its own LegitScript-certified pharmacy in Mississauga. MyRocky also serves all 10 provinces (Felix and Hims do not operate in Quebec) and has been trusted by 350,000+ Canadians. Visit MyRocky or read our full MyRocky review.
| Provider | Monthly Cost (Mounjaro) | Consultation Fee | Coverage | Learn More |
|---|---|---|---|---|
| MyRocky ⭐ Top Pick | $300–$310 | $99 once (lab work included) | All 10 provinces | Visit MyRocky |
| Felix Health | Brand $250–$310 / Generic $149+ | $99 setup + $40 quarterly | All provinces except QC | Visit Felix |
| Maple | $270–$320 | $69 per consult | All provinces | Visit Maple |
| Hims Canada | Generic semaglutide available — pricing on consult | Included | Select provinces | Visit Hims |
| Jill Health | Pricing on assessment | Included in program | Most provinces | Visit Jill |
| DooU | Pricing on assessment | Included in program | Most provinces | Visit DooU |
| Raven | Pricing on assessment | Included in program | Most provinces | Visit Raven |
Provider reviews: MyRocky (top pick), Felix, Maple, Hims Canada, Jill Health, DooU and Raven.
All six telehealth services on this list accept new patients from Nova Scotia as of April 2026. Felix and Maple are the most common choices for active Mounjaro prescribing - the others lean toward off-label semaglutide.
For a full scenario-by-scenario provider comparison, read Best Mounjaro Providers in Canada.
Pharmacy Options and Pricing in Nova Scotia
Mounjaro retail pricing in Nova Scotia scales with dose strength - unlike Wegovy, where every pen costs the same. Single-dose pre-filled pens are sold as a box of 4 (one per week, 4 weeks of therapy). [1]
| Dose | Monthly Cost (Retail) | Annual Cost | Titration Phase |
|---|---|---|---|
| 2.5 mg weekly | $280 to $310 | $3,360 to $3,720 | Weeks 1 to 4 |
| 5 mg weekly | $310 to $350 | $3,720 to $4,200 | Weeks 5 to 8 |
| 7.5 mg weekly | $360 to $400 | $4,320 to $4,800 | Weeks 9 to 12 |
| 10 mg weekly | $400 to $450 | $4,800 to $5,400 | Weeks 13 to 16 |
| 12.5 mg weekly | $450 to $500 | $5,400 to $6,000 | Weeks 17 to 20 |
| 15 mg weekly | $500 to $550 | $6,000 to $6,600 | Week 21+ |
Many Nova Scotians stabilize at 10 mg or 12.5 mg and never titrate to 15 mg. Holding at the lower effective dose saves $50 to $150 per month versus the maximum dose.
Pharmacy Comparison in Nova Scotia (10 mg dose)
| Pharmacy | 10 mg Monthly Price | Dispensing Fee | Membership Required? |
|---|---|---|---|
| Costco Pharmacy | $390 to $410 | $4.49 | No (for pharmacy use) |
| Walmart Pharmacy | $405 to $430 | $9.97 | No |
| Shoppers Drug Mart | $415 to $440 | $11.99 | No (PC Optimum points apply) |
| Rexall | $410 to $435 | $11.49 | No |
| Independent pharmacies | $400 to $450 | $8 to $15 | No |
Costco Pharmacy is consistently the lowest in-store Mounjaro price across Nova Scotia where Costco operates - roughly $30 to $40 per month less than Shoppers Drug Mart. No Costco membership is required to use the pharmacy in Canada. Smaller centres without a Costco may benefit from licensed online pharmacies with temperature-controlled shipping. Full provincial pricing detail at Mounjaro at Costco Canada.
Major Nova Scotia Cities With Mounjaro-Filling Pharmacies
Halifax, Sydney, Dartmouth, Truro, New Glasgow all have multiple licensed pharmacies stocking Mounjaro. Rural Nova Scotia residents often do better with mail-order from a Canadian online pharmacy than local pickup, because Mounjaro pens require temperature-controlled storage that smaller pharmacies sometimes hesitate to keep.
myMounjaro Savings Card in Nova Scotia
Eli Lilly Canada runs the myMounjaro patient-support program - one of the more generous savings cards in the Canadian GLP-1 market. Registration is online at mymounjaro.ca or through the prescribing clinic, and the card is accepted at most major Canadian pharmacy chains. [3]
Eligibility
- Valid Canadian prescription for Mounjaro.
- Canadian residential address (provincial address required for some pharmacy chains).
- Not currently covered by a government drug plan for Mounjaro - private-insurance patients can still apply the card against their copay.
Real-World Out-of-Pocket Scenarios in Nova Scotia
| Scenario | Insurance Covers | Savings Card Covers | Patient Pays |
|---|---|---|---|
| Private insurance (80% coverage) | $240 to $440 | Up to card maximum | $0 to $60 |
| Private insurance (70% coverage) | $196 to $385 | Up to card maximum | $0 to $115 |
| No insurance | $0 | Up to card maximum | $130 to $400 |
| Nova Scotia Pharmacare covers Mounjaro | Full or most | Card not eligible | Provincial copay only |
The card historically offsets in the $100 to $150 per month range. Combined with private insurance, monthly out-of-pocket for Nova Scotians can sit near zero. Verify current terms at mymounjaro.ca before budgeting because Eli Lilly adjusts the program annually.
Medical Expense Tax Credit for Mounjaro Spending
Out-of-pocket Mounjaro costs count as eligible medical expenses for the federal Medical Expense Tax Credit (METC). For the 2026 tax year, the threshold is the lesser of $2,834 or 3 percent of net income. Because Mounjaro runs $280 to $550 per month, a full year of out-of-pocket tirzepatide easily clears the METC floor for most Nova Scotians. Keep every pharmacy receipt - the CRA accepts them as supporting documentation. [7]
Nova Scotia adds a provincial tax-credit component on top of the federal METC. Couples can pool eligible medical expenses on whichever spouse has the lower net income to maximize the claim.
Mounjaro vs Ozempic vs Wegovy in Nova Scotia
Nova Scotians weighing tirzepatide against semaglutide alternatives benefit from the head-to-head comparison below. Mounjaro is the most expensive at retail but produces the largest average weight reduction in clinical trials. [5]
| Factor | Mounjaro (tirzepatide) | Ozempic (semaglutide) | Wegovy (semaglutide) |
|---|---|---|---|
| Drug class | Dual GIP/GLP-1 agonist | GLP-1 agonist | GLP-1 agonist |
| Approved use in Canada | Type 2 diabetes | Type 2 diabetes | Chronic weight management |
| Monthly retail cost | $280 to $550 | $250 to $375 | $540 to $570 |
| Costco price | $390 to $410 (10 mg) | $250 to $265 (1.0 mg) | $490 to $520 (2.4 mg) |
| Savings card | myMounjaro ($100 to $150/mo) | None | NovoCare ($100 to $150/mo) |
| Nova Scotia Pharmacare coverage | Not listed | Covered for T2D | Not covered |
| Average trial weight loss | 15 to 22% | 10 to 15% | 14 to 16% |
| Generic timeline | Patents in force into 2030s | Generic launching 2026 | Generic late 2026/early 2027 |
For a full molecule-level comparison, see Mounjaro vs Ozempic and Wegovy vs Mounjaro. The 2026 generic semaglutide launch may widen the cost gap meaningfully for price-sensitive patients - timeline detail at Generic Semaglutide in Canada.
FAQ
Is Mounjaro covered by Nova Scotia Pharmacare?
Not yet. Nova Scotia Pharmacare does not list Mounjaro on its formulary as of April 2026. The province is awaiting its provincial review following pCPA. Until a listing decision lands, Nova Scotians cover Mounjaro through private insurance or self-pay.
How do I get Mounjaro covered by private insurance in Nova Scotia?
Ask your prescriber to submit a prior-authorization request to your insurer (Manulife, Sun Life, Canada Life or others depending on your plan). Include lab work, your A1C if T2D, BMI documentation if weight-related, and a prescriber letter explaining why tirzepatide is medically appropriate. Most Nova Scotia insurers approve T2D claims within two to four weeks; weight-management claims take longer and have higher denial rates.
What is the cheapest pharmacy for Mounjaro in Nova Scotia?
Costco Pharmacy runs $390 to $410 for the 10 mg dose - roughly $30 to $40 below Shoppers Drug Mart. You do not need a Costco membership to use the pharmacy in Canada. Smaller centres without a Costco can use licensed online pharmacies for similar pricing.
Can I get Mounjaro for weight loss in Nova Scotia?
Yes, off-label. Health Canada has approved Mounjaro for type 2 diabetes only, but Canadian physicians can prescribe it off-label for weight management. Eli Lilly has not yet launched the on-label weight-management brand (Zepbound) in Canada. Telehealth clinics like Felix Health and Maple regularly handle off-label tirzepatide prescriptions when BMI criteria are met.
Does the myMounjaro savings card stack with private insurance?
In most cases yes. Submit your claim to private insurance first, then apply the myMounjaro card against the remaining copay. The card cannot stack with full government drug-plan coverage.
When will generic Mounjaro be available?
Not in this decade. Eli Lilly’s tirzepatide patents are in force in Canada well into the 2030s. The generic launching in 2026 is semaglutide (Ozempic and eventually Wegovy), not tirzepatide. Patients prioritizing low cost can now consider generic semaglutide, available in Canadian pharmacies since May 2026 at roughly $88 per month at Costco.
Are there any tirzepatide telehealth clinics that prescribe in Nova Scotia?
Yes - all six major Canadian telehealth clinics (Felix Health, Maple, Hims Canada, Jill Health, DooU, Raven) accept new patients from Nova Scotia. Felix and Maple are the strongest choices for active Mounjaro prescribing.
This article is informational and is not a substitute for medical advice from your prescribing clinician. Always confirm pricing and coverage directly with the pharmacy and your insurer before filling.
Sources
- Health Canada Drug Product Database: Mounjaro (tirzepatide): Official Canadian Mounjaro product listing including approved indication, dose-by-pen pricing structure and titration schedule.
- Nova Scotia Pharmacare Programs: Official Program Information: Provincial drug plan rules and formulary lookup for Nova Scotia.
- Eli Lilly Canada: myMounjaro Patient Support Program: myMounjaro savings card eligibility criteria, monthly savings range and enrollment process.
- Nova Scotia Pharmacare Formulary: Tirzepatide Listing: Check current formulary listing and coverage conditions for tirzepatide in Nova Scotia.
- SURMOUNT-1 Clinical Trial: Tirzepatide for Weight Loss (NEJM, 2022): 72-week phase-3 weight-management trial of tirzepatide showing 15 to 22 percent average body-weight reduction.
- Costco Canada: Pharmacy Services: Costco Canada pharmacy access does not require a warehouse membership under provincial pharmacy regulation.
- Canada Revenue Agency: Medical Expense Tax Credit: 2026 tax-year METC threshold of $2,834 and prescription-drug eligible-expense rules.
- Health Canada: Generic Semaglutide Pipeline (2026): Generic semaglutide submissions under Health Canada review following the January 4, 2026 data-exclusivity expiry.
- Drug Shortages Canada: Mounjaro Supply Status: Health Canada-run site tracking current Mounjaro and tirzepatide supply status by pen strength.
- Pan-Canadian Pharmaceutical Alliance: Mounjaro Negotiation Status: pCPA negotiation outcomes that drive provincial-formulary listing decisions for Mounjaro.